Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Chinese Medical Journal
|
September 10, 2024
Efficacy and safety of avatrombopag in the treatment of thrombocytopenia after umbilical cord blood transplantation
Aijie Huang, Guangyu Sun, Baolin Tang, et al.
Oncogene
|
September 23, 2021
CD8<sup>+</sup> T effector and immune checkpoint signatures predict prognosis and responsiveness to immunotherapy in bladder cancer
Xingyu Chen, Runshi Xu, Dong He, et al.
Oncogene
|
August 16, 2020
LINC00467 is up-regulated by TDG-mediated acetylation in non-small cell lung cancer and promotes tumor progression
Yuxing Zhu, Jingjing Li, Hao Bo, et al.
Chinese Journal of Natural Medicines
|
November 30, 2023
Identification of Bulbocodin D and C as novel STAT3 inhibitors and their anticancer activities in lung cancer cells
Xinyu He, Jiarui Fu, Wenyu Lyu, et al.
Experimental Hematology & Oncology
|
July 3, 2025
Prophylactic infusion of allogeneic double-negative T cells as immune modulators to prevent relapse in high-risk AML patients post-Allo-HSCT: a phase I trial
Guangyu Sun, Xingchi Chen, Tianzhong Pan, et al.
American Journal of Cancer Research
|
December 9, 2020
Long non-coding RNA FOXD1-AS1 promotes the progression and glycolysis of nasopharyngeal carcinoma by sustaining FOXD1 expression
Zhanwang Wang, Yaxin Cheng, Yuxing Zhu, et al.
Cancer Cell International
|
June 9, 2020
Ubiquitin ligase CHAF1B induces cisplatin resistance in lung adenocarcinoma by promoting NCOR2 degradation
Lian Gong, Yi Hu, Dong He, et al.
Frontiers in Oncology
|
May 20, 2020
WDHD1 Leads to Cisplatin Resistance by Promoting MAPRE2 Ubiquitination in Lung Adenocarcinoma
Lian Gong, Mengqing Xiao, Dong He, et al.
Nanoscale
|
June 21, 2021
Se@Albumin nanoparticles ameliorate intestinal mucositis caused by cisplatin via gut microbiota-targeted regulation
Liping Deng, Hongliang Zeng, Xueying Hu, et al.
Annals of Hematology
|
November 20, 2025
Ruxolitinib as second-line therapy for bronchiolitis obliterans syndrome after hematopoietic cell transplantation: a retrospective multicenter study
Yuqing Tu, Lingyi Yang, Yaxin Cheng, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Chinese Medical Journal
|
September 10, 2024
Efficacy and safety of avatrombopag in the treatment of thrombocytopenia after umbilical cord blood transplantation
Aijie Huang, Guangyu Sun, Baolin Tang, et al.
Oncogene
|
September 23, 2021
CD8<sup>+</sup> T effector and immune checkpoint signatures predict prognosis and responsiveness to immunotherapy in bladder cancer
Xingyu Chen, Runshi Xu, Dong He, et al.
Oncogene
|
August 16, 2020
LINC00467 is up-regulated by TDG-mediated acetylation in non-small cell lung cancer and promotes tumor progression
Yuxing Zhu, Jingjing Li, Hao Bo, et al.
Chinese Journal of Natural Medicines
|
November 30, 2023
Identification of Bulbocodin D and C as novel STAT3 inhibitors and their anticancer activities in lung cancer cells
Xinyu He, Jiarui Fu, Wenyu Lyu, et al.
Experimental Hematology & Oncology
|
July 3, 2025
Prophylactic infusion of allogeneic double-negative T cells as immune modulators to prevent relapse in high-risk AML patients post-Allo-HSCT: a phase I trial
Guangyu Sun, Xingchi Chen, Tianzhong Pan, et al.
American Journal of Cancer Research
|
December 9, 2020
Long non-coding RNA FOXD1-AS1 promotes the progression and glycolysis of nasopharyngeal carcinoma by sustaining FOXD1 expression
Zhanwang Wang, Yaxin Cheng, Yuxing Zhu, et al.
Cancer Cell International
|
June 9, 2020
Ubiquitin ligase CHAF1B induces cisplatin resistance in lung adenocarcinoma by promoting NCOR2 degradation
Lian Gong, Yi Hu, Dong He, et al.
Frontiers in Oncology
|
May 20, 2020
WDHD1 Leads to Cisplatin Resistance by Promoting MAPRE2 Ubiquitination in Lung Adenocarcinoma
Lian Gong, Mengqing Xiao, Dong He, et al.
Nanoscale
|
June 21, 2021
Se@Albumin nanoparticles ameliorate intestinal mucositis caused by cisplatin via gut microbiota-targeted regulation
Liping Deng, Hongliang Zeng, Xueying Hu, et al.
Annals of Hematology
|
November 20, 2025
Ruxolitinib as second-line therapy for bronchiolitis obliterans syndrome after hematopoietic cell transplantation: a retrospective multicenter study
Yuqing Tu, Lingyi Yang, Yaxin Cheng, et al.
Page
of 7